Myelo Therapeutics GmbH

myelotherapeutics.com

myelotherapeutics.com • Berlin

Berlin

Actively hiring

As featured in

Reuters

FinanzNachrichten.de

Overview

News

Salaries

Products

People

Growth

Offices

Financials

Overview

0 Research and Development About Newsroom Contact Us Mission Statement Our company is dedicated to advancing the health and well-being of individuals affected by radiation exposure, be it through a nuclear strike, accident or during cancer treatment.

News

News reuters.com 6 years ago

Eckert & Ziegler Increases Stake In Myelo Therapeutics Read more

Report

News FinanzNachrichten.de 8 years ago

Myelo Therapeutics GmbH: FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome

Myelo Therapeutics GmbH / FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome . Processed and transmitted by West Corporation. The issuer

Report

Offices

Where the company hires and what each office is for

Cities

Hiring now

Countries

Berlin Germany

Registered seat

company site